Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H RUBIN

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Biochemical Pharmacology|April 4, 1997
Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysisX G Li, P Haluska, Y H Hsiang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2018
Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnosticS P Kang, K Gergich, G M Lubiniecki, et al.
Annals of Neurology|May 1, 1988
Mild senile dementia of the Alzheimer type: 2. Longitudinal assessmentL Berg, J P Miller, M Storandt, et al.
Neurology|April 1, 1991
Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal agingJ C Morris, D W McKeel, M Storandt, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|June 5, 1998
High-performance liquid chromatographic quantitation of total and lactone 20(S)camptothecin in patients receiving oral 20(S)camptothecinF Ahmed, V Vyas, A Saleem, et al.
Archives of Neurology|January 1, 1988
Reliability of the Washington University Clinical Dementia RatingW J Burke, J P Miller, E H Rubin, et al.
Investigational New Drugs|July 5, 2008
Optimal modeling for phase I design of a two drug combination-results of a phase I study of cisplatin with 9-nitrocamptothecinS-J Lee, M Gounder, E H Rubin, et al.
Diabetes Care|August 1, 1995
Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trialP J Lustman, L S Griffith, R E Clouse, et al.
Archives of General Psychiatry|December 15, 2000
Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosisN B Farber, E H Rubin, J W Newcomer, et al.
Psychosomatic Medicine|May 1, 1997
Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trialP J Lustman, L S Griffith, R E Clouse, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|April 4, 1997
Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysisX G Li, P Haluska, Y H Hsiang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2018
Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnosticS P Kang, K Gergich, G M Lubiniecki, et al.
Annals of Neurology|May 1, 1988
Mild senile dementia of the Alzheimer type: 2. Longitudinal assessmentL Berg, J P Miller, M Storandt, et al.
Neurology|April 1, 1991
Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal agingJ C Morris, D W McKeel, M Storandt, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|June 5, 1998
High-performance liquid chromatographic quantitation of total and lactone 20(S)camptothecin in patients receiving oral 20(S)camptothecinF Ahmed, V Vyas, A Saleem, et al.
Archives of Neurology|January 1, 1988
Reliability of the Washington University Clinical Dementia RatingW J Burke, J P Miller, E H Rubin, et al.
Investigational New Drugs|July 5, 2008
Optimal modeling for phase I design of a two drug combination-results of a phase I study of cisplatin with 9-nitrocamptothecinS-J Lee, M Gounder, E H Rubin, et al.
Diabetes Care|August 1, 1995
Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trialP J Lustman, L S Griffith, R E Clouse, et al.
Archives of General Psychiatry|December 15, 2000
Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosisN B Farber, E H Rubin, J W Newcomer, et al.
Psychosomatic Medicine|May 1, 1997
Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trialP J Lustman, L S Griffith, R E Clouse, et al.
Pageof 9